SODIUM ROSE BENGAL I 131 Drug Patent Profile
✉ Email this page to a colleague
When do Sodium Rose Bengal I 131 patents expire, and when can generic versions of Sodium Rose Bengal I 131 launch?
Sodium Rose Bengal I 131 is a drug marketed by Sorin and is included in one NDA.
The generic ingredient in SODIUM ROSE BENGAL I 131 is rose bengal sodium i-131. There are one hundred and four drug master file entries for this compound. Additional details are available on the rose bengal sodium i-131 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SODIUM ROSE BENGAL I 131?
- What are the global sales for SODIUM ROSE BENGAL I 131?
- What is Average Wholesale Price for SODIUM ROSE BENGAL I 131?
Summary for SODIUM ROSE BENGAL I 131
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 3 |
| DailyMed Link: | SODIUM ROSE BENGAL I 131 at DailyMed |
Recent Clinical Trials for SODIUM ROSE BENGAL I 131
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | N/A |
| Universidade Federal do Rio de Janeiro | Phase 4 |
| Santen Pharmaceutical Co., Ltd. | Phase 3 |
US Patents and Regulatory Information for SODIUM ROSE BENGAL I 131
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sorin | SODIUM ROSE BENGAL I 131 | rose bengal sodium i-131 | INJECTABLE;INJECTION | 017318-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
